Investigation of the prevalence and risk factors of Helicobacter pylori infection and the value of different gastric cancer screening methods in a low-risk region of gastric cancer in China

被引:1
作者
Liao, Foqiang [1 ]
Zhu, Zhenhua [1 ,2 ]
Zhu, Shusheng [3 ]
Wan, Jianhua [1 ,2 ]
Fan, Chenglai [3 ]
Zhang, Xu [1 ,3 ]
Shu, Xu [1 ,2 ]
Lu, Nonghua [1 ,2 ]
机构
[1] Nanchang Univ, Digest Dis Hosp, Affiliated Hosp 1, Dept Gastroenterol, 17 Yongwaizheng St, Nanchang 330006, Jiangxi, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 1, Jiangxi Clin Res Ctr Gastroenterol, Nanchang, Jiangxi, Peoples R China
[3] Yudu Cty Peoples Hosp, Dept Gastroenterol, Ganzhou, Jiangxi, Peoples R China
关键词
Helicobacter pylori; gastric cancer; screening method; epidemiological survey; risk factor; SERUM PEPSINOGENS; CHILDREN; WINE;
D O I
10.1080/07853890.2023.2243988
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The aim of this current study was to identify the prevalence and risk factors of H. pylori infection in the low-risk area of gastric cancer in China, and evaluate the value of different gastric cancer screening methods.Methods An epidemiological study was conducted in Yudu County, Jiangxi, China, and participants were followed up for 6 years. All participants completed a questionnaire, laboratory tests and endoscopy. Patients were divided into H. pylori positive and negative groups, and risk factors for H. pylori infection were identified using multivariate logistic regression analysis.Results A total of 1962 residents were included, the prevalence of H. pylori infection was 33.8%. Multivariate analysis showed that annual income =20,000 yuan (OR: 1.44, 95% CI: 1.18-1.77, p < 0.001), loss of appetite (OR: 1.71, 95% CI: 1.29-2.26, p < 0.001), PG II >37.23 ng/mL (OR: 2.11, 95% CI: 1.50-2.97, p < 0.001), G-17 > 1.5 and =5.7 pmol/L (OR: 2.52, 95% CI: 1.93-3.30, p < 0.001), and G-17 > 5.7 pmol/L (OR: 1.96, 95% CI: 1.48-2.60, p < 0.001) were risk factors of H. pylori infection, while alcohol consumption (OR: 0.70, 95% CI: 0.54-0.91, p = 0.006) was a protective factor. According to the new gastric cancer screening method, the prevalence of low-grade intraepithelial neoplasia in the low-risk group, medium-risk group and high-risk group was 4.4%, 7.7% and 12.5% respectively (p < 0.001).Conclusions In a low-risk area of gastric cancer in China, the infection rate of H. pylori is relatively low. Low income, loss of appetite, high PG II, and high G-17 were risk factors for H. pylori infection, while alcohol consumption was a protective factor. Moreover, the new gastric cancer screening method better predicted low-grade intraepithelial neoplasia than the ABC method and the new ABC method.
引用
收藏
页数:8
相关论文
共 34 条
  • [1] Prediction of Chronic Atrophic Gastritis and Gastric Neoplasms by Serum Pepsinogen Assay: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy
    Bang, Chang Seok
    Lee, Jae Jun
    Baik, Gwang Ho
    [J]. JOURNAL OF CLINICAL MEDICINE, 2019, 8 (05)
  • [2] Prevalence, incidence and risk factors for Helicobacter pylori infection in a cohort of Portuguese adolescents (EpiTeen)
    Bastos, Joana
    Peleteiro, Barbara
    Pinto, Hugo
    Marinho, Ana
    Guimaraes, Joao T.
    Ramos, Elisabete
    La Vecchia, Carlo
    Barros, Henrique
    Lunet, Nuno
    [J]. DIGESTIVE AND LIVER DISEASE, 2013, 45 (04) : 290 - 295
  • [3] Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study
    Cai, Quancai
    Zhu, Chunping
    Yuan, Yuan
    Feng, Qi
    Feng, Yichao
    Hao, Yingxia
    Li, Jichang
    Zhang, Kaiguang
    Ye, Guoliang
    Ye, Liping
    Lv, Nonghua
    Zhang, Shengsheng
    Liu, Chengxia
    Li, Mingquan
    Liu, Qi
    Li, Rongzhou
    Pan, Jie
    Yang, Xiaocui
    Zhu, Xuqing
    Li, Yumei
    Lao, Bo
    Ling, Ansheng
    Chen, Honghui
    Li, Xiuling
    Xu, Ping
    Zhou, Jianfeng
    Liu, Baozhen
    Du, Zhiqiang
    Du, Yiqi
    Li, Zhaoshen
    [J]. GUT, 2019, 68 (09) : 1576 - 1587
  • [4] Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands
    Chiang, Tsung-Hsien
    Chang, Wei-Jung
    Chen, Sam Li-Sheng
    Yen, Amy Ming-Fang
    Fann, Jean Ching-Yuan
    Chiu, Sherry Yueh-Hsia
    Chen, Yi-Ru
    Chuang, Shu-Ling
    Shieh, Chun-Fu
    Liu, Cheng-Ying
    Chiu, Han-Mo
    Chiang, Hung
    Shun, Chia-Tung
    Lin, Ming-Wei
    Wu, Ming-Shiang
    Lin, Jaw-Town
    Chan, Chang-Chuan
    Graham, David Y.
    Chen, Hsiu-Hsi
    Lee, Yi-Chia
    [J]. GUT, 2021, 70 (02) : 243 - 250
  • [5] Pepsinogen II in gastritis and Helicobacter pylori infection
    Di Mario, Francesco
    Crafa, Pellegrino
    Barchi, Alberto
    Franzoni, Lorella
    Franceschi, Marilisa
    Russo, Michele
    Bricca, Ludovica
    Brozzi, Lorenzo
    Castro, Kryssia Rodriguez
    Rugge, Massimo
    [J]. HELICOBACTER, 2022, 27 (02)
  • [6] Risk factors associated with Helicobacter pylori infection among children in a defined geographic area
    Dore, MP
    Malaty, HM
    Graham, DY
    Fanciulli, G
    Delitala, G
    Realdi, G
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 35 (03) : 240 - 245
  • [7] Functional Gastrointestinal Disorders 3 Functional dyspepsia
    Ford, Alexander C.
    Mahadeva, Sanjiv
    Carbone, M. Florencia
    Lacy, Brian E.
    Talley, Nicholas J.
    [J]. LANCET, 2020, 396 (10263) : 1689 - 1702
  • [8] Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis
    Ford, Alexander Charles
    Yuan, Yuhong
    Moayyedi, Paul
    [J]. GUT, 2020, 69 (12) : 2113 - 2121
  • [9] Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: Comparative study with type and severity of gastritis
    Haj-Sheykholeslami, Arghavan
    Rakhshani, Naser
    Amirzargar, Aliakbar
    Rafiee, Reza
    Shahidi, S. Mehdi
    Nikbin, Behrouz
    Khosravi, Farideh
    Massarrat, Sadegh
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (02) : 174 - 179
  • [10] Chinese and global burdens of gastric cancer from 1990 to 2019
    He, Yuxin
    Wang, Yida
    Luan, Fujuan
    Yu, Zhuwen
    Feng, Huang
    Chen, Bingxin
    Chen, Weichang
    [J]. CANCER MEDICINE, 2021, 10 (10): : 3461 - 3473